JPRN-UMIN000019865已完成未知
A Phase II clinical trial to evaluate the efficacy and safety of intra-arterial infusion chemotherapy for head and neck squamous cell carcinoma - A Phase II clinical trial of intra-arterial infusion chemotherapy for head and neck SCC
Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 40 人开始时间: 2015年11月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. History of intolerance or hypersensitivity to drugs which will be used or any excipient of the product. 2. Current pregnancy 3. Current known active infection 4. Uncontrolled diabetes 5. Severe heart disease 6. Severe pulmonary disease 7. Patients who are judged to be inappropriate for participation in this study.
研究者
相似试验
撤回
不适用
A phase II clinical Trial for evaluating efficacy and safety of PDR001(Spartalizumab) in concurrent plus consolidation versus consolidation only in addition to standard chemotherapy in unresectable stage III NSCLC patients(PASTURE)KCT0004933Yonsei University Health System, Severance Hospital200
进行中（未招募）
2 期
A Clinical Study to evaluate the efficacy and safety of NRC-AN-019 in cancer patients failing prior standard therapiesCTRI/2013/06/003768ATCO Pharma Limited
招募中
2 期
Phase II Clinical Study to evaluate the efficacy and safety of NRC-2694-ACTRI/2019/06/019649ATCO Pharma Ltd
进行中（未招募）
1 期
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-000810-44-ESFundació Sant Joan de Déu30
进行中（未招募）
不适用
Clinical Trial testing the combination of MK-5172 and MK-8742 with Ribavirin in people with Hepatitis CHepatitis C Virus Genotype 2, 4, 5 and 6MedDRA version: 16.1Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: LLTClassification code 10047457Term: Viral hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2013-002169-21-GBMerck Sharp & Dohme Corp.100